273 related articles for article (PubMed ID: 30848565)
1. Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34
Martinez AF; Miller WM
Stem Cells Transl Med; 2019 Jul; 8(7):658-670. PubMed ID: 30848565
[TBL] [Abstract][Full Text] [Related]
2. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production.
Panuganti S; Schlinker AC; Lindholm PF; Papoutsakis ET; Miller WM
Tissue Eng Part A; 2013 Apr; 19(7-8):998-1014. PubMed ID: 23190353
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential.
Panuganti S; Papoutsakis ET; Miller WM
Cytotherapy; 2010 Oct; 12(6):767-82. PubMed ID: 20482285
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N
Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
[TBL] [Abstract][Full Text] [Related]
7. Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release.
Kishore V; Eliason JF; Matthew HW
J Biomed Mater Res A; 2011 Mar; 96(4):682-92. PubMed ID: 21268241
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
De Bruyn C; Delforge A; Martiat P; Bron D
Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of early and late megakaryocyte progenitors.
Lefebvre P; Winter JN; Meng Y; Cohen I
J Hematother Stem Cell Res; 2000 Dec; 9(6):913-21. PubMed ID: 11177605
[TBL] [Abstract][Full Text] [Related]
10. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.
Jaimes Y; Gras C; Goudeva L; Buchholz S; Eiz-Vesper B; Seltsam A; Immenschuh S; Blasczyk R; Figueiredo C
J Thromb Haemost; 2012 Jun; 10(6):1100-8. PubMed ID: 22448926
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor-dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets.
Strassel C; Brouard N; Mallo L; Receveur N; Mangin P; Eckly A; Bieche I; Tarte K; Gachet C; Lanza F
Blood; 2016 May; 127(18):2231-40. PubMed ID: 26966088
[TBL] [Abstract][Full Text] [Related]
13. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD61- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells.
Schipper LF; Brand A; Fibbe WE; Van Hensbergen Y
Stem Cells; 2012 May; 30(5):988-96. PubMed ID: 22378601
[TBL] [Abstract][Full Text] [Related]
15. [In vitro expansion and function of cord blood megakaryocyte].
Ju XL; Shi Q; Huang ZW; Hou HS; Sun NZ; Zhao Y; Shen BJ
Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):64-8. PubMed ID: 17349156
[TBL] [Abstract][Full Text] [Related]
16. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.
Mattia G; Vulcano F; Milazzo L; Barca A; Macioce G; Giampaolo A; Hassan HJ
Blood; 2002 Feb; 99(3):888-97. PubMed ID: 11806991
[TBL] [Abstract][Full Text] [Related]
17. Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.
Sim X; Jarocha D; Hayes V; Hanby HA; Marks MS; Camire RM; French DL; Poncz M; Gadue P
Blood; 2017 Jul; 130(2):192-204. PubMed ID: 28455282
[TBL] [Abstract][Full Text] [Related]
18. Influence of medium components on ex vivo megakaryocyte expansion.
van den Oudenrijn S; von dem Borne AE; de Haas M
J Hematother Stem Cell Res; 2001 Feb; 10(1):193-200. PubMed ID: 11276373
[TBL] [Abstract][Full Text] [Related]
19. Cotransplantation of ex vivo expanded progenitors with nonexpanded cord blood cells improves platelet recovery.
Émond H; Boyer L; Roy DC; Pineault N
Stem Cells Dev; 2012 Nov; 21(17):3209-19. PubMed ID: 22783996
[TBL] [Abstract][Full Text] [Related]
20. Dynamin 3 participates in the growth and development of megakaryocytes.
Reems JA; Wang W; Tsubata K; Abdurrahman N; Sundell B; Tijssen MR; van der Schoot E; Di Summa F; Patel-Hett S; Italiano J; Gilligan DM
Exp Hematol; 2008 Dec; 36(12):1714-27. PubMed ID: 19007685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
